Didier Betbeder
7Patents
4h-index
22Co-inventors
57Inventor score
Filing activity: Apr 2, 1992 → Sep 13, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6017513A | Mucosal administration of substances to mammals | Emerging Cross-Sectional Technologies | 40 | Expired |
| US6096291A | Mucosal administration of substances to mammals | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6342226B1 | Method for increasing immunogenicity, product obtained and pharmaceutical compositions | Chemistry; Metallurgy | 7 | Expired |
| US5348863A | Process for the enzymatic preparation of basic fibroblast growth factor | Chemistry; Metallurgy | 4 | Expired |
| US6214621A | Conjugates of a particle vector and oligonucleotides, process for their preparation, and pharmaceutical compositions containing them | Chemistry; Metallurgy | 1 | Expired |
| US9731005B2 | Pharmaceutical composition comprising a solid nanoparticle and at least an antigen for the treatment against an intracellular pathogenic agent | Emerging Cross-Sectional Technologies | 0 | Active |
| US6759060B2 | Synthetic particulate vectors and preparation process | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.